Infliximab, methotrexate and their combination for the treatment of rheumatoid arthritis: a systematic review and meta-analysis.

about

Infliximab, methotrexate and their combination for the treatment of rheumatoid arthritis: a systematic review and meta-analysis.

Item

http://www.wikidata.org/entity/Q38320157

description

2014 nî lūn-bûn

@nan

2014年の論文

@ja

2014年学术文章

@wuu

2014年学术文章

@zh-cn

2014年学术文章

@zh-hans

2014年学术文章

@zh-my

2014年学术文章

@zh-sg

2014年學術文章

@yue

2014年學術文章

@zh

2014年學術文章

@zh-hant

name

Infliximab, methotrexate and t ...... atic review and meta-analysis.

@en

type

Item

label

Infliximab, methotrexate and t ...... atic review and meta-analysis.

@en

prefLabel

Infliximab, methotrexate and t ...... atic review and meta-analysis.

@en

P1476

Infliximab, methotrexate and t ...... atic review and meta-analysis.

@en

P2093

Alessandra Maciel Almeida

http://www.w3.org/2001/XMLSchema#string

Eli Iola Gurgel Andrade

http://www.w3.org/2001/XMLSchema#string

Francisco de Assis Acurcio

http://www.w3.org/2001/XMLSchema#string

Juliana de Oliveira Costa

http://www.w3.org/2001/XMLSchema#string

Lívia Lovato Pires de Lemos

http://www.w3.org/2001/XMLSchema#string

Marina Amaral de Ávila Machado

http://www.w3.org/2001/XMLSchema#string

Mariângela Leal Cherchiglia

http://www.w3.org/2001/XMLSchema#string

Vânia de Eloísa Araújo

http://www.w3.org/2001/XMLSchema#string

P2860

Systematic review and meta-analysis of the efficacy and safety of existing TNF blocking agents in treatment of rheumatoid arthritis

Pharmaceutical industry sponsorship and research outcome and quality: systematic review

The Measurement of Observer Agreement for Categorical Data

2012 update of the 2008 American College of Rheumatology recommendations for the use of disease-modifying antirheumatic drugs and biologic agents in the treatment of rheumatoid arthritis

The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration

The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis

Infliximab and methotrexate in the treatment of rheumatoid arthritis. Anti-Tumor Necrosis Factor Trial in Rheumatoid Arthritis with Concomitant Therapy Study Group

Serious infection following anti-tumor necrosis factor alpha therapy in patients with rheumatoid arthritis: lessons from interpreting data from observational studies.

Tumor necrosis factor alpha drugs in rheumatoid arthritis: systematic review and metaanalysis of efficacy and safety.

Infliximab (chimeric anti-tumour necrosis factor alpha monoclonal antibody) versus placebo in rheumatoid arthritis patients receiving concomitant methotrexate: a randomised phase III trial. ATTRACT Study Group.

P2888

j.rbr.2014.10.009

P304

146-158

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

meta-analysis

P356

10.1016/J.RBR.2014.10.009

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Adriana Maria Kakehasi

P577

2014-11-29T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

269729428

http://www.w3.org/2001/XMLSchema#string

P6179

1023529817

http://www.w3.org/2001/XMLSchema#string

P698

25593074

http://www.w3.org/2001/XMLSchema#string